An early meta-analysis of 16 studies of patients with COVID-19 receiving systemic cancer
therapy, found an increased risk of death in those receiving chemotherapy within the past …

Patients with cancer generally have a higher risk of adverse outcomes from COVID-19, with
higher age, male sex, poor performance status, cancer type, and uncontrolled malignant …

Simple Summary Patients with cancer who contract COVID-19 are very vulnerable to
increased complications and illness while actively being treated with chemotherapy or …

Importance Cytokine storm due to COVID-19 can cause high morbidity and mortality and
may be more common in patients with cancer treated with immunotherapy (IO) due to …

Background: ICI are widely used in the treatment of various cancer types. It has been
hypothesized that ICI could confer an increased risk of severe acute lung injury or other …

Dear Editor, The coronavirus disease 2019 (COVID-19) pandemic has affected over
6,000,000 people globally [1]. Patients with COVID-19 manifest with symptoms of fever, dry …

Thehypoxia and profound inflammatory response associated with the pneumonitisobserved
with the SARS-CoV-2 virus responsible for the recent COVID-19 pandemic has …

As of 22nd December 2020, the United Kingdom (UK) reported 2,110,314 cases of
coronavirus disease (COVID-19) with 79,349 deaths (1). There have been subsequent …

Since the end of 2019, global healthcare systems have been dealing with the COVID-19
pandemic. In oncology, the biggest questions concern interaction of COVID-19 with pre …

Background Amid continued uncertainty about the management of cancer patients during
the pandemic, this study sought to obtain real-world data on the use of immune checkpoint …